Kristin Powell

Kristin Powell supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in facilitating critical procurement activities that enable public health infrastructure and scientific response capabilities. She manages complex acquisitions for high-stakes laboratory diagnostics, biomedical research tools, and data systems essential to infectious disease surveillance and outbreak response. Her work ensures the CDC’s operational readiness by securing mission-critical technologies and services that underpin national health security initiatives, with a focus on rapid deployment and technical precision in high-demand domains. Powell maintains strategic relationships with leading providers in the public health and life sciences sectors, including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid. These partnerships reflect a preference for established industry leaders with proven expertise in diagnostic instrumentation, biosafety-compliant supply chains, and integrated data platforms. Her contracting approach emphasizes performance-based outcomes, technical compliance, and long-term service reliability, often involving multi-year task orders and indefinite-delivery/indefinite-quantity (IDIQ) mechanisms to ensure continuity of critical operations. Powell’s procurement portfolio reflects no set-aside preferences, with 100% of awards issued under full and open competition. This indicates a prioritization of technical capability and mission-critical performance over socioeconomic classifications, aligning with the CDC’s urgent operational needs where specialized expertise and proven scalability are paramount. While small business participation is not formally targeted, all acquisitions adhere to federal acquisition regulations and competitive fairness standards. Her primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 423430 (Computer and Computer Peripheral Equipment and Software Merchant Wholesalers), underscoring deep expertise in procuring advanced diagnostic analyzers, PCR systems, clinical laboratory automation, and secure health data infrastructure. She specializes in acquiring technologies that support real-time pathogen detection, genomic sequencing, and epidemiological data integration—core capabilities for modern public health response.